| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 inhibits the expression of DME CYP2C18 |
[1] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Butyraldehyde |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00999
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Butyraldehyde up-regulates the expression of DME CYP2C18 |
[2] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Coal tar |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00755
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Coal tar up-regulates the expression of DME CYP2C18 |
[3] |
| Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Mixture |
| DME Modulation |
Tobacco smoke pollution inhibits the drug-metabolizing activity of DME CYP2C18 |
[4] |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Senecionine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01585
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Senecionine inhibits the drug-metabolizing activity of DME CYP2C18 |
[5] |
| Walrycin A |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01498
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Walrycin A up-regulates the expression of DME CYP2C18 |
[6] |
| Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Plant extracts |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01574
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Plant Extract |
| DME Modulation |
Plant extracts inhibits the drug-metabolizing activity of DME CYP2C18 |
[7], [8] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen inhibits the expression of DME CYP2C18 |
[9], [10] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME CYP2C18 |
[11] |
| Rifampin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00223
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Rifampin inhibits the expression of DME CYP2C18 |
[12] |
| Tretinoin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Tretinoin inhibits the expression of DME CYP2C18 |
[13] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| (+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
(+)-JQ1 inhibits the expression of DME CYP2C18 |
[14] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Beta-naphthoflavone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01220
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Beta-naphthoflavone inhibits the expression of DME CYP2C18 |
[15] |
|
|
|
|
|
|